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Abstract 
In 2009, 2.6 million people in the United States over 12 years of age received treatment for substance abuse at a "specialty 
facility" . The direct cost of substance abuse treatment was estimated to be $22 billion in 2005, up from $11 billion in 1991. With 
recent federal health care reform, more clients may seek treatment, but it is unclear how this would affect clinics' costs per client. 
Although past studies on substance abuse costs find some evidence of economies of scale, they also find wide variation in the 
average costs of treatment, the reasons for which require further investigation. As a result, state substance abuse agencies and 
other payers face difficulty in determining how to pay providers, in fact, very often funding is inadequate or wasted. The drug 
abuse treatment process can be viewed as a complex adaptive system in which system inputs such as workers, physical capital 
and other materials are converted into outputs such as treatment completions and outcomes. Treatment clinics desire the most 
cost efficient input mix to generate desired outputs. Although substance abuse researchers are ahead of many other fields in 
developing and refining instruments such as the Drug Abuse Treatment Cost Analysis Program, many of these instruments are 
restricted by the fact that databases have many omissions making it difficult to answer research questions that might otherwise be 
informed by economic analysis. Additionally, due to the large numbers of variables involved, trade-offs are difficult to explore. 
Questions such as “what are the relationships between costs and case-mix?” or “what are reasonable reimbursement rates for 
substance abuse treatment and how do they differ for specialized populations such as heroin users?”  are difficult to answer. The 
work reported in this paper provides significant insight that can help policymakers to decide where to focus funding through 1) 
prediction of missing treatment data and 2) identification of critical variables. 
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1. Introduction 
Some of the most difficult decisions that government policymakers face are which substance abuse treatment 
programs to fund and where to set reimbursement rates. Similarly, a challenge facing both Federal and State 
policymakers is how to efficiently allocate limited public funds while avoiding either over or under treating 
substance-abusing patients. In principle, only programs that meet some minimum set of performance standards 
should be funded, and reimbursement rates should be linked to the economic cost of service provision, clinical 
outcomes, and economic benefits. In 2009, 2.6 million people at least 12 years of age received treatment for 
substance abuse at a “specialty facility” [1]. The direct cost of substance abuse treatment was estimated to be $22 
billion as of 2005 [2] up from $11 billion in 1991 [3]. In 1998, community-based specialty drug treatment costs were 
about $4.9 billion [4]. State substance abuse agencies and other payers face difficulty in determining how to pay 
providers, typically resulting in either inadequate or over allocation of resources. Quality and effectiveness of drug 
abuse treatment is important because of current difficult fiscal conditions in many states that necessitate directing 
limited resources in the most efficient manner. Treatment outcomes are a good indicator of quality and effectiveness 
since these focus on whether clients have successfully completed their treatments and achieved specific results. 
Efficient drug abuse treatment is plagued by two major problems: 1) incomplete data on treatment variables and 
costs; 2) large number of hard-to-track variables that determine total functional cost of treatment. The work reported 
in this paper provides significant insight that can help policymakers to decide where to focus funding by (i) 
predicting crucial missing data with a high degree of statistical confidence and (ii) identifying those variables that 
are most critical in determining system cost. 
2. Description of Data 
Data employed for this work was obtained from IRS 990 forms [5] submitted by the drug treatment facilities. It 
consists of a huge database of alcohol and chemical dependency data for 300 clinics in Minnesota over a 5-year 
period (2007-11) as well as financial information for a subset of these clinics. Operating expenses were matched 
with annual clinic-level client counts, completions, and outcomes data from state agencies. Furthermore, a database 
of geographical information on the distance between pairs of clinics was created. The data was organized in three 
categories as described below. 
 
I. Patient Profile Data 
This data consists of 34 items of background information about each patient obtained on admission to treatment. 
Examples of items in this category (see table 1) include: i) gender, age, race; ii) primary substance - alcohol, heroin, 
cocaine; iii) source of referral - self, family, employer, criminal justice system; iv) source of income - job, 
retirement, family, friends, no income. 
 
II. Treatment Outcome Data 
This data describes 11 different conditions in which the patient leaves treatment providing information at discharge 
regarding patient’s status in critical domains of living. Examples of items in this category (see table 2) include: i) 
patient completed program; ii) patient left without approval; iii) patient judged inappropriate; iv) death; v) % age 
change in # homeless after versus before treatment; vi) % age change in # of arrests after versus before treatment;  
vii) % age change in # drug use after versus before treatment. 
 
III. Financial Cost Data 
This data consists of 42 measures of employee and clinic-related expenses. Examples of items in this category (table 
3) include i) employee-related expenses - compensation, salaries and wages, employee benefits; ii) clinic-related 
expenses - accounting, professional fees, postage/shipping, telephone, legal fees; iii) total functional expenses; iv) 
property value - land, buildings,  equipment; v) grants and special assistance - cash and non-cash. 
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Table 1 Sample Patient Profile Data for four clinics (units: fraction 0-1) 
Clinic 
# Male Female  White Black Hispanic 18-25 26 -34 Alcohol Heroin Cocaine 
1 0.784 0.216 0.049 0.944 0 0.204 0.401 0.463 0.019 0.093 
2 0.608 0.392 0.839 0.021 0.014 0.273 0.28 0.608 0.014 0 
3 1 0 0.717 0.217 0 0.13 0.152 0.717 0.065 0.087 
4 0.884 0.116 0.828 0.056 0.047 0.329 0.273 0.541 0.054 0.054 
 
Table 2 Sample Treatment Outcomes Data (units: fraction 0-1)              Table 3 Sample Financial/Cost Data for four clinics (units: $000) 
Clini
c # 
Complete
d 
program 
Left 
without 
approva
l 
Judged 
inappropriat
e 
Death/ 
other 
Clini
c # 
Salaries/Wage
s Total 
Pension 
plan 
contribution
s 
Other 
employe
e 
benefits 
Payroll 
taxes 
Accountin
g fees 
1 0.284 0.333 0.025 0.358 1 1073178 0 76914 103159 27935 
2 0.692 0.105 0.105 0.098 2 403340 13536 74990 52340 1853 
3 0.543 0.326 0.065 0.065 3 544491 10757 100612 52766 4950 
4 0.646 0.138 0.138 0.078 4 2474598 0 461994 260796 9000 
 
In each category, for some years (see tables 4.1 and 4.2) there are many missing items of data. However, due to the 
large volume of data, it was possible to predict missing data using artificial neural networks as reported in section 4 
below. 
 
Table 4.1  Patient Profile - Missing Data (2007)                             Table 4.2  Financial/Cost - Missing Data (2007) 
Data Type Dimensions Missing Data Data Type 
Dimensions & 
Range Missing Data 
Patient Profile     Financial/Cost     
# of Clients  Natural #s row 23 Employee Related Expenses $(0-40m) USD  rows 10 & 23 
Gender % row 23 Clinic Related Expenses $(0-2m) USD rows 10 & 23 
Race % row 23 Separated Expenses  $(0-7m) USD rows 10 & 23 
Age % row 23 Total Function Cost  $(0-95m) USD rows 10 & 23 
Primary 
Substance  % row 23 Properties Value  $(0-120m) USD rows 10 & 23 
Source of 
Referral % row 23 
Total Number of 
Employees 0-1000 rows  5,10 & 23 
Source of 
Income % row 23 
Grants and Special 
Assistance $(0-50K) USD row 12 
 
3. Complex Adaptive Systems Optimization  
3.1. Complex Adaptive System  
Drug abuse treatment can be viewed as a production process in which system inputs are combined in the 
treatment process to generate outputs (see figure 1). The production process can be modeled as a complex adaptive 
system in which system inputs are converted into outputs. System inputs are (i) workers – clinicians, nurses, 
physicians etc; (ii) physical capital – buildings, structures, furniture etc and (iii) other materials including 
medications and supplies. Outputs are treatment completions and outcomes. The objective of complex adaptive 
system optimization is to determine how much of a product should be manufactured, and the optimal method of 
production in order to maximize throughput while minimizing the average production costs. In the specific case of 
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substance abuse treatment, when clinics are not using the right input mix (see figure 2), resources are wasted and 
many clients may not get optimal care. The problem of efficiency optimization of drug abuse clinics is an extremely 
complex one since there are many diverse client-based and facility-related variables to be considered including 
socio-economic factors, demographics, treatment type and financial data. When the extra output per additional dollar 
spent on workers is greater than the extra output per additional dollar spent on capital, then optimization implies that 
clinics should change their input mix by hiring more workers and using less capital. 
Figure 1 Substance Abuse Treatment Modelled as Production Process                                              Figure 2: Desirable Input Mix  
                                               
3.2. Missing Data: Total Functional Cost
Total functional cost (TFC) is a clinic’s total cost of operation including all employee and clinic-related expenses 
obtained from IRS Form 990 for most of the treatment facilities. TFC associated with a production process can be 
used to inform decisions on investment needs as well as the number and sizes of entities required for optimal 
functioning of industry as a whole. TFC can be used as an objective function in the economic analysis of complex 
adaptive drug treatment systems to provide answers to questions such as “ does one treatment produce a better 
outcome at the same cost as another or comparable outcomes at less cost?” TFC was missing in many instances from 
our database, as such our first task was to predict it accurately.  
3.3 Missing Data: Total Number of Employees
Total number of employees (TNE) is a critical economic parameter in determining a clinic’s operational costs. In 
our database, the TNE ranged from 0 (missing data) to 1000 with many missing entries. Given the pressing need for 
current and rigorous economic cost information that can assist government policymakers with their funding 
decisions, we set out to update and improve the substance abuse treatment database with regard to total number of 
employees. 
4. Prediction of Missing Data 
4.1. Total Functional Cost (TFC) 
After appropriate normalization of data to ensure a reasonable dynamic range, a 29-30-1 backpropagation neural 
network was constructed to predict the TFC. Neural network design and prototyping software Professional Plus II by 
Neuralware Inc. was employed. The 29 inputs to the network ranged from patient profile information such as age, 
primary substance and referral source to outcome data such as discharge status and financial data such as employee 
costs and property value. The single output from the backpropagation network was the total functional cost.  
Parameters of the backprop net were as follows: 
Epoch size (E)=8   Learning Coefficient Hidden Layer =0.6 Learning  Coefficient Output Layer = 0.3
Momentum Term (M)=0.4  Number of PE’s in hidden layer (N)=30 Number of training sets (T) = 94 
Training data consisted of about 80% of the database - sets of inputs and outputs from clinics for which the TFC was 
known. Test data included all clinics for which TFC was missing as well as a number of clinics for which the TFC 
was known, about 20% of the database. This enabled us to determine accuracy of prediction of TFC. After several 
thousand presentations of the training data to the network using the sigmoid activation function, test results indicated 
that TFC was predicted with better than 1% accuracy as shown in table 5. Samples of actual and predicted TFC 
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values are listed in table 6 and plotted in the scatter diagram in figure 3. 
 
Table 5 Neural Network Prediction of TFC        Table 6 Actual versus Predicted TFC 
 
# of 
Presentations 
RMS 
Err 
Training 
RMS 
Err 
Test   
Actual 
TFC 
Predicted 
TFC 
  Activation TF = Sigmoid ($million) ($million) 
50000 0.0035 0.0188 5.294317 6.488828 
100000 0.0038 0.0165 1.507144 2.190346 
120000 0.0054 0.022 0.366195 1.005017 
140000 0.0027 0.0121   1.737187 2.160785 
200000 0.0017 0.0099 10.116715 8.938443 
300000 0.0031 0.0111 1.879102 2.259012 
Minimum RMS Test Err 
=  0.0099    1.84319 1.719046 
 
Figure 3: Actual versus Predicted Total Functional Cost ($million)                 Figure 4: Actual Versus Predicted Total Number of Employees  
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Results indicate that the missing TFC data was predicted with a high degree of statistical confidence (99%) 
thereby supplying important financial outcome data for economic analysis of drug treatment at the facilities. 
4.2. Total Number of Employees (TNE) 
In a similar manner to that employed for TFC prediction, a 30-40-1 backpropagation neural network was 
constructed to predict the TNE. The 30 inputs to the network also ranged from patient profile information such as 
age, primary substance and referral source to outcome data such as discharge status and financial data such as 
employee costs and property value. The single output from the backpropagation network was the total number of 
employees.  Parameters of the backprop net were as follows: 
Epoch size (E) = 8   Learning Coefficient Hidden Layer = 0.6  Learning Coefficient Output Layer = 0.3 
Momentum Term (M) = 0.4  Number of PE’s in hidden layer (N) = 40  Number of training sets (T) = 80 
Training data consisted of  about 85% of the database - sets of inputs and outputs from clinics for which the TNE 
was known. Test data included all clinics for which TNE was missing as well as a number of clinics for which the 
TNE was known, about 15% of the database. This enabled us to determine accuracy of prediction of TNE. After 
several thousand presentations of the training data to the network using once again the sigmoid activation function, 
test results indicated that TNE was predicted with better than 2% accuracy. Tables of test results and actual and 
predicted TNE values are not included for reasons of space, however a scatter diagram of actual versus predicted 
TNE is shown in figure 4. 
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5.  Complex Adaptive System Optimization - Sensitivity Analysis  
Simplification of the drug abuse treatment process can be achieved by reducing the number of input variables 
based on sensitivity analysis. Changes in outputs such as total functional cost or total number of employees with 
respect to changes in input variables such as client demographic information can be very valuable in the 
optimization process. The neural network used in the prediction of outputs automatically provided accurate 
estimates of normalized small change sensitivity of outputs with respect to each of the input variables. Both the 
magnitude and sign of the sensitivity are important. 
5.1. Impact of Input Variables - Total Functional Cost Optimization 
The neural network used in the prediction of TFC provided accurate estimates of small change sensitivity for TFC 
with respect to each of the 29 input variables. Specifically, the following 5 input variables were found to have the 
largest sensitivities, hence were  the most critical in determining TFC: percentages of 1)white clients, 2) 
American/Indian clients, 3) Asian/Pacific clients, 4) methamphetamine users and 5) heroin users. In all 5 cases, the 
sign of sensitivity was negative, i.e. if the magnitude was increased, the TFC was reduced. In contrast, two input 
variables were found to have the least impact on TFC: percentages of  1) alcohol users  and 2) marijuana primary 
substance users. This information is currently being used for gradient based optimization of TFC. 
5.2. Impact of Input Variables on Total Number of Employees 
The neural network used in the prediction of TNE  also provided accurate estimates of small change sensitivity for 
TNE with respect to each of the 30 input variables. Specifically, one input variable was found to have the largest 
sensitivity hence it was the most critical in determining TNE. The input variable was the percentage of clients under 
the age of 18. The indication was that large numbers of clients under 18 increased significantly the number of 
employees required. This information is currently being employed to guide decisions on optimal deployment of 
clinical staff. 
6. Conclusions and Further Work 
A method is described for successful and accurate neural net prediction of missing drug abuse treatment data and for 
the identification of those variables that are most critical in determining treatment costs. This is the first step in the 
application of cost function analysis - a method used by economists to examine the costs of production in a 
particular industry – to the problem of efficient drug abuse treatment. The drug abuse treatment process is a 
production process that can be modeled as a complex adaptive system for which functional cost optimization can be 
undertaken to maximize throughput while minimizing the average production costs. Future work will employ the 
results of this work – a robust drug abuse database together with sensitivity information – for the design of state 
drug abuse treatment facilities for optimal efficiency of operation. 
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